Zoetis Stock News

Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mednax (MD) purchases Night Lite Pediatrics, LLC in Orlando to enhance its pediatric business line.

The FDA approves Sanofi's (SNY) Enjaymo for the treatment of hemolysis in adult patients with cold agglutinin disease. Enjaymo is the first therapy to be approved for this indication.

NEW YORK, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Zoe , a digital wealth platform leader in connecting clients with leading financial advisors, is pleased to introduce one of their new Advisor Network partners. After a lengthy vetting process designed to ensure they provide top-of-the-line financial planning and investment management with a client-first mindset, Zoe is pleased to announce that Pure Financial Advisors was accepted as a registered independent advisory firm (RIA) partner. Pure Financial Advisors, ranked among RIA Channel''s Top 100 ETF Power Users and Advisory HQ''s Top 12 San Diego Financial Advisors & RIAs , was founded in 2007 by Michael Fenison. His goal was to create positive change in the financial industry by building a financial planning firm that emphasized tax planning and an institutional approach to investing. Importantly, Pure Financial was designed to be free from all conflicts of interest, and to act as fiduciaries, always placing their clients'' interests above their own.

Zoetis Inc. found using ticker (ZTS) now have 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 264 and 220 with the average target price sitting at 246.33. Given that the stocks previous close was at 200.92 this would imply there is a potential upside of 22.6%. The 50 day moving average now sits at 219.35 and the 200 day MA is 201.79. The market capitalisation for the company is $94,408m. Visit the company website at: https://www.zoetis.com [stock_market_widget type="chart" symbol="ZTS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $115,745m based on the market concensus. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

General Motors Co., Tesla Inc., Marvell Technology Inc., FedEx Corp. and Zoetis Inc are highlighted in this Analyst Blog article.

We have narrowed our search to five U.S. corporate giants (market capital > $50 billion) that are currently trading on the dip. These are: TSLA, GM, FDX, MRVL and ZTS.

We have narrowed our search to five U.S. corporate giants (market capital > $50 billion) that are currently trading on the dip. These are: TSLA, GM, FDX, MRVL and ZTS.

Both of these companies are leaders in their respective industries.

Both of these companies are leaders in their respective industries.

As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks. The post 7 of the Top-Rated Pharmaceutical Stocks for Q1 appea

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

The FDA has approved Zoetis Inc''s (NYSE: ZTS ) Solensia (frunevetmab injection) to control the pain of osteoarthritis (OA) in cats, helping improve their mobility, comfort, and overall well-being. Solensia, prescribed as a once-monthly injection administered in the veterinary clinic, controls OA pain by targeting Nerve Growth Factor (NGF), a key driver in OA pain. The Full story available on Benzinga.com

The FDA has approved Zoetis Inc's (NYSE: ZTS) Solensia (frunevetmab injection) to control the pain of osteoarthritis (OA) in cats, helping improve their mobility, comfort, and overall well-being.